Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Stroke in Korean Young Adults Study (SKY)

10. Februar 2016 aktualisiert von: Young Seo Kim, Hanyang University
The main objective of this study is to determine the risk factors and etiologies of ischemic stroke in Korean young adults. Both well-documented risk factors and little known life-style related risk factors such as life-style habits, psychological distress including occupational distress, perceived stress and depression will be evaluated by comparison with healthy controls using a structured questionnaire. Secondary objectives are to determine stroke outcomes such as mortality, recurrent vascular events and post-stroke epilepsy in these patients.

Studienübersicht

Status

Unbekannt

Detaillierte Beschreibung

All consecutive patients who had their first-ever ischemic stroke symptoms within the previous month will be asked to enroll in the study. Baseline measurements will be assessed in all patients. Patients without language problems or life-threatening conditions will be asked to answer the structured lifestyle questionnaire. Age- and sex-matched controls without a stroke history will be recruited among patients' friends, relatives and the care-givers of other patients, and will be requested to complete the same questionnaire. People who visit hospital for health check-ups may also be included as controls. After the first assessment, all patients will be followed every 3 months during visits to the outpatient department or by telephone. Participants will be asked about recurrence of stroke, occurrence of post-stroke epilepsy, and functional outcomes on the modified Rankin Scale. In the case of patients who have died, information will be obtained from their last practitioner or care-giver.

Sample size and power calculation. The sample sizes were calculated based on the frequency of psychological distress, which is the most interesting potential risk factor for ischemic stroke in the young. According to a previous report comparing psychological distress in ischemic stroke patients and healthy controls,8 the frequency of stress was 50.3% in the ischemic stroke patients and 38.6% in the healthy controls; a difference of 11.7%. To detect such a difference with a power of 90% and alpha of 0.05 with a drop-out rate of 20%, a sample size of at least 470 patients and 470 controls will be needed (PASS 13).

Clinical information. Demographic and clinical information will be collected on admission.The data include age, gender, traditional risk factors for stroke (hypertension, diabetes, hyperlipidemia, smoking and coronary heart disease), medication history (anti-hypertensives, anti-diabetics, anti-platelets and statins) and other comorbidities. Hypertension is defined as previous use of antihypertensive medication, systolic blood pressure ≥140 mmHg or diastolic BP ≥90 mmHg at discharge, diabetes as previous use of antidiabetic medication or fasting blood glucose ≥126 mg/dL, and hyperlipidemia as previous use of lipid-lowering agents, fasting serum total cholesterol ≥240 mg/dL or low-density lipoprotein ≥160 mg/dL. With regard to cigarette smoking, subjects will be classified as current, former, or non-smokers. Number of pack-years will be noted for former and current smokers. History of coronary heart disease is defined as previous angina pectoris, myocardial infarction, or coronary artery bypass grafting. Patients will also be asked about any other comorbid diseases.

Stroke characteristics and laboratory investigations. Data on stroke characteristics will be collected at admission, including symptoms at time of onset and pre-hospital delay. Severity of stroke will be measured on the National Institutes of Health Stroke Scale (NIHSS) by physicians certified by the Clinical Research Center for Stroke in Korea. The course of the disease during admission will be established, including treatments and complications. On discharge, each case of ischemic stroke will be classified according to the TOAST classification. Modified Rankin Scale (mRS) and Barthel index scores will also be obtained at discharge. Laboratory investigations including complete blood cell count, erythrocyte sedimentation rate, C-reactive protein, urinalysis, urine pregnancy test, serum electrolytes, liver function test, renal function tests, chest X-ray and electrocardiogram will be checked in the emergency department. Other specific laboratory investigations such as fasting blood glucose, hemoglobin A1C, lipid panel test, thyroid function test, rheumatologic panel tests, hypercoagulable panel tests, heavy metal tests, homocysteine and α-galactosidase will be checked on the day after admission, following overnight fasting. For the genetic test for CADASIL, investigators will ask for a further informed consent. All patients will undergo cardiac evaluation during the admission period, including 24-hour Holter monitoring, transthoracic echocardiography and transesophageal echocardiography.

Neuroimaging. Brain imaging studies will be interpreted by more than one neuro-radiologist at each center without any knowledge of the clinical information. Standardized magnetic resonance image (MRI) sequences will be recommended to all participating centers. The minimal requirements for brain imaging studies are diffusion-weighted images, FLAIR images, T2-weighted images, and gradient echo images. All participants will undergo additional vascular imaging studies such as CT angiography, MR angiography or digital subtraction angiography. Based on the neuroimaging, ischemic stroke location, size and vascular territories will be noted. The diagnosis and treatment of stroke will follow the standard guidelines of each coordinating center.

Life style questionnaires. After making the baseline measurements, a standardized life style questionnaire will be provided to all patients who do not have a language problem. Age- and sex-matched healthy controls will be asked the same questions. The standardized questionnaire again requests demographic data such as age, gender, height, weight, abdominal circumference, traditional risk factors, medication history and other comorbidities. Newly-added demographic data include family history of risk factors, ABO type, marital status, living status, economic status, educational status and presence of pain and headache. Marital status is classified as married, single, divorced or widowed. Living status is classified as alone, with spouse, with family, or with non-family member. Economic status is classified into five categories (500 USD/month, 500~1500 USD/month, 1500~3000 USD/month, 3000~5000 USD/month and >5000 USD/month) and educational status is classified into six categories (none, <6 years, 6-9 years, 9-12 years, 12 years, >12 years). Questions about headaches are mainly focused on migraine: headache character, location, frequency, duration, aura, aggravating factors, medication history and family history. Only women will answer questions about obstetric history in terms of age at menarche and menopause (if participants have experienced them), use of oral contraceptives, history of hormone replacement therapy, and history of hysterectomy or oophorectomy. Women who have experienced pregnancy are asked about gravidity, number of children, years of births, mode of delivery, duration of maternal lactation, and number of miscarriages or abortions.

Lifestyle factors such as alcohol consumption, dietary habits, exercise and sleep patterns are included in the questions. Alcohol consumption is defined as type of alcoholic drink, amount per day and date when consumption began. Dietary habits include meal frequency and consumption of salts, meats, vegetables and 7 types of beverages (coffee, black tea, oolong tea, green tea, ginseng tea, fruit juice and carbonated beverage) during the past year. Exercise will be calculated according to the International Physical Activity Questionnaire (IPAQ), which is a standardized instrument for measuring the amount of exercise.9 Duration of sleep, sleep latency, frequency of waking-up after sleep onset (WASO), snoring severity, duration of naps, history of using sleeping pills and length of time in bed without sleeping will be reported to evaluate sleep patterns. Investigators will also add the validated Korean version of the Epworth Sleepiness Scale for measuring daytime sleepiness,10 and questions about restless leg syndrome.

Psychological distress will be analyzed by a composite measure of occupational distress, perceived stress, and depression. For occupational distress, both occupational status and job strain will be analyzed. Not only occupation type but also period of service in the current and previous occupation will be noted to evaluate occupational status. Average daily working hours, commuting method (car, bus, subway, walk or other) and commuting time (less than 30 minutes, 30 minutes to 1 hour, 1 hour to 2 hours or more than 2 hours) will also be recorded. Job strain will be investigated by means of a job content questionnaire (JCQ) validated in the Korean language.

Perceived stress and depression will be answered on the basis of premorbid status. The Perceived Stress Scale (PSS) and Center of Epidemiologic Studies Depression scale (CES-D) Korean version, which have been validated in the relevant fields, will be used to measure the subjective status of patients and controls.

Statistical analysis. The study will comprise 470 case-control pairs. Means with standard deviations will be calculated for continuous variables, and numbers with percentages will be obtained for discrete variables. To assess the relationship between characteristics and ischemic stroke in young adults, investigators will use paired t-tests for continuous variables and chi-square tests for proportions. For nonparametric variables, the Mann-Whitney U test will be used.

Conditional logistic regression analysis will be employed to assess differences between cases and matched controls by estimating odds ratios (ORs) and 95% confidence intervals (CIs). Adjusted ORs for risk factors will be derived from multivariable logistic regression models. These will include all collected variables with possible significance. Kaplan-Meier survival analysis will be used to estimate cumulative risk of mortality, recurrent vascular events and post-stroke seizure. Hazard ratios for the previously-mentioned secondary objectives will be calculated by Cox regression analysis, and assumptions of proportionality will be confirmed by time-dependent covariate analysis. All the statistical analyses will be two-sided and will use IBM SPSS 21.

Studientyp

Beobachtungs

Einschreibung (Voraussichtlich)

470

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre bis 44 Jahre (Erwachsene)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Alle

Probenahmeverfahren

Wahrscheinlichkeitsstichprobe

Studienpopulation

Patients who had their first-ever ischemic stroke symptoms within the previous month and visited one of the 8 participating tertiary medical centers in the Republic of Korea.

Beschreibung

Inclusion Criteria:

  1. Age 18 through 44 years
  2. First-ever acute ischemic stroke with corresponding lesion on MRI scan
  3. Onset of symptoms within 1 months of inclusion

Exclusion Criteria:

  1. Any history of stroke
  2. No verification by MRI scan
  3. Failure to give their informed consent

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Zeitfenster
Evidence of clinically definite ischemic stroke (focal neurological deficits persisting for more than 24 hours) confirmed by non-investigational CT or MRI
Zeitfenster: Through study completion, an average of 4 years
Through study completion, an average of 4 years

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
All cause mortality
Zeitfenster: 4 years
Information will be obtained from participant's last practitioner or care-giver.
4 years
Recurrent stoke asked by using questionnaires
Zeitfenster: 4 years
Minimum necessary time interval between original event and recurrent stoke is 21 days. If a stroke occured within 21 days, it has to be located in the different vascular territory as the original event.
4 years
Myocardial infarction asked by using questionnaires
Zeitfenster: 4 years
Subsequent fatal or nonfatal myocardial infarction
4 years
Post-stroke epilepsy asked by using questionnaires
Zeitfenster: 4 years
Two or more unprovoked epileptic seizures occuring at ≥1 week after the ischemic stroke event.
4 years

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn

1. Dezember 2013

Primärer Abschluss (Voraussichtlich)

1. Dezember 2016

Studienabschluss (Voraussichtlich)

1. Dezember 2018

Studienanmeldedaten

Zuerst eingereicht

9. Februar 2016

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

10. Februar 2016

Zuerst gepostet (Schätzen)

17. Februar 2016

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Schätzen)

17. Februar 2016

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

10. Februar 2016

Zuletzt verifiziert

1. Februar 2016

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

UNENTSCHIEDEN

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren